[PRLD] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 5.26%
YoY- -76.16%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -19,250 -16,760 -11,408 -9,511 -10,039 -6,734 -5,399 132.49%
Tax 0 0 0 0 0 0 0 -
NP -19,250 -16,760 -11,408 -9,511 -10,039 -6,734 -5,399 132.49%
Tax Rate - - - - - - - -
Total Cost 19,250 16,760 11,408 9,511 10,039 6,734 5,399 132.49%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.51 -0.44 -0.30 -0.29 -0.31 -0.21 -3.43 -71.77%
EPS Diluted -0.51 -0.44 -0.30 -0.29 -0.31 -0.21 -3.42 -71.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.